ARMISTICE CAPITAL LLC other names

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}
{{ Info.Homepage }}

Adviser Profile

As of Date:

05/31/2024

Adviser Type:

- Large advisory firm

Number of Employees:

28 12.00%

of those in investment advisory functions:

17 41.67%

Registration:

SEC, Approved, 7/2/2015

Other registrations (1)
AUM:

5,911,150,000 6.40%

of that, discretionary:

5,911,150,000 6.40%

Private Fund GAV:

5,911,150,000 6.40%

Avg Account Size:

1,970,383,333 6.40%

SMA’s:

NO

Private Funds:

1

Contact Info

212 xxxxxxx

Websites :
Client Types:

+

Advisory Activities:

+

Compensation Arrangments:

+

Reported AUM

Discretionary
Non-discretionary
6B 5B 4B 3B 2B 2B 794M
2015 2016 2017 2018 2019 2020 2021 2022 2023

Recent News

Hedge Fund Beats Vaxart Investors 'Short-Swing' Profits Suit - USA Herald
03/30/2024

In a dramatic turn of events, a New York federal judge has delivered a decisive victory to hedge fund Armistice Capital LLC and its chief ...

usaherald.com

Hedge Fund Beats Vaxart Investor's 'Short-Swing' Profits Suit - Law360
03/29/2024

A New York federal judge has granted a win to hedge fund Armistice Capital LLC and its managing member in a derivative suit brought by a ...

law360.com

Prominent Healthcare Hedge Fund Armistice Capital LLC Reduces Stake in ... - Best Stocks
06/16/2023

Armistice Capital LLC, a prominent New York-based hedge fund that specializes in healthcare investment, has shocked the market with its decision ...

beststocks.com

Hedge Fund Armistice Must Face Vaxart Insider Trading Claims - Bloomberg Law News
05/27/2023

Shareholders of Covid-19 vaccine developer Vaxart Inc. adequately stated insider trading and scheme participation claims against Armistice Capital ...

news.bloomberglaw.com

Top 5 3rd Quarter Trades of ARMISTICE CAPITAL, LLC
11/15/2022

Related Stocks: SPY, IWM, GSK, FRPT, ROST,

gurufocus.com

Armistice Capital Shows New 5.5% Stake in Freshpet
09/23/2022

investing.com


Private Funds Structure

Fund Type Count GAV
Hedge Fund 1 $5,911,150,000

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM # funds
WESTPORT CAPITAL PARTNERS LLC 6.7b - - - - - - 6.7b 6.5b 30
SPX CAPITAL MANAGEMENT LLC 5.1b - - - - - - 5.1b 359.7m 15
VR ADVISORY SERVICES LTD. 6.4b - - - - - - 6.4b 6.4b 2
EMPYREAN CAPITAL PARTNERS, LP 5.0b - - - - - - 5.0b 5.0b 1
SOUTHEASTERN ASSET MANAGEMENT INC. 131.0m - - - - - - 131.0m 5.3b 3
LEADENHALL CAPITAL PARTNERS 2.4b - - - - - - 2.4b 4.7b 9
EXCHANGE TRADED CONCEPTS, LLC - - - - - - - - 5.5b -
EMSO ASSET MANAGEMENT LIMITED 553.2m - - - - - - 553.2m 4.5b 3
CANDLESTICK CAPITAL MANAGEMENT LP 6.1b - - - - - - 6.1b 6.1b 2
ROCK SPRINGS CAPITAL 5.8b - - - - - - 5.8b 5.8b 2

Private Funds



Employees




Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
78462F103 SPDR S&P 500 ETF TR (PUT) $2,122,458,000 27.00% 13.00% 8.00%
464287655 ISHARES TR (PUT) $1,947,744,000 25.00% 5.00% 9.00%
69366J200 PTC THERAPEUTICS INC $212,904,902 3.00% 8.00% 3.00%
868459108 SUPERNUS PHARMACEUTICALS INC $141,026,000 2.00% 16.00% 48.00%
64125C109 NEUROCRINE BIOSCIENCES INC $134,708,443 2.00% -5.00% -4.00%
G5960L103 MEDTRONIC PLC $64,897,261 1.00% 18.00% 30.00%
49271V100 KEURIG DR PEPPER INC $49,634,504 1.00% 212.00% 186.00%
558868105 MADRIGAL PHARMACEUTICALS INC $42,024,000 1.00% -6.00% -11.00%
50127T109 KURA ONCOLOGY INC $48,386,500 1.00% 11.00% 15.00%
30063P105 EXACT SCIENCES CORP $59,153,634 1.00% 17.00% 92.00%

Brochure Summary

Overview

Armistice Capital, LLC (“Armistice”), a Delaware limited liability company, is an investment management firm located in New York that commenced operations on May 1, 2012. Steven J. Boyd (the “Managing Member”) is Armistice’s principal and majority owner. Armistice provides discretionary investment advisory services to private investment funds (the “Funds” or the “Advisory Clients”), which include: Armistice Capital Fund LP, a Delaware limited partnership that launched on July 1, 2012 (the “Domestic Fund”); Armistice Capital Offshore Fund Ltd., an exempted company incorporated under the laws of the Cayman Islands that launched on August 1, 2012 (the “Offshore Fund”); and Armistice Capital Master Fund Ltd., an exempted company incorporated under the laws of the Cayman Islands (the “Master Fund”) that launched on July 1, 2012. The Domestic Fund and the Offshore Fund (together, the “Feeder Funds”) invest substantially all of their assets in the Master Fund, through a master-feeder fund structure. It should also be noted that Armistice Capital GP, LLC (the “General Partner”), an affiliate of Armistice, is also majority owned by Mr. Boyd and acts as General Partner to the Domestic Fund. The Feeder Funds, through their investments in the Master Fund, seek to achieve long-term capital appreciation by employing an opportunistic global long/short strategy for investing primarily in equity securities, equity-related instruments, debt investments, and other assets. In all
of its investing activities, the Funds seek to emphasize capital preservation and seek to mitigate risk through various hedging strategies at both the position and portfolio levels. To achieve this objective, the Funds seek to focus on strategic value, event, and thematic investment opportunities (both long and short) in a variety of industries. It should be noted that the Funds invest a portion of their assets in illiquid investments (with some limitation), including, investments in securities of non-public companies. While it is anticipated that the Funds will continue to invest primarily in equities and equity-related securities in the both the U.S. and non-U.S. markets, Armistice has broad and flexible investment authority with respect to the Funds. The Funds have entered into and may in the future enter into agreements (“Side Letters”) with certain prospective or existing investors whereby such investors are subject to terms and conditions that are more advantageous than those set forth in the respective Fund’s offering documents. The modifications are solely at the discretion of Armistice and may, among other things, be based on the size of the investor’s investment in the Funds, an agreement by an investor to maintain such investment in the Funds for a significant period of time, or other similar commitment by an investor to the Funds. As of December 31, 2023, Armistice managed approximately $5,911,150,000of regulatory assets on a discretionary basis.